Latest News about COVID/19 Coronavirus
Recent news which mentions COVID/19 Coronavirus
Quest Diagnostics Updates 2021 Outlook On Surging Demand Of COVID-19 Tests
September 09, 2021
Tickers
DGX
From Benzinga
EMA To Add New Side Effects To Janssen, AstraZeneca COVID-19 Shots
September 08, 2021
From Benzinga
AIM ImmunoTech To Test Ampligen In Post-COVID-19 Cognitive Dysfunction
September 08, 2021
Tickers
AIM
From Benzinga
Novavax Starts COVID-19, Flu Combination Vaccine Trial
September 08, 2021
Tickers
NVAX
From Benzinga
From Benzinga
FDA Questions Kaleido Biosciences 'Non-IND' COVID-19 Trial
September 07, 2021
Tickers
KLDO
From Benzinga
COVID-19 Vaccine Booster Shots Will Have To Wait, FDA Tells White House: WSJ
September 03, 2021
From Benzinga
From Benzinga
AstraZeneca, EU Reach Settlement On COVID-19 Vaccine Delivery
September 03, 2021
From Benzinga
White House Commits $3B To Boost COVID-19 Vaccine Supply Chain: Report
September 03, 2021
From Benzinga
Can Vaccine Help In Long Term COVID-19 Symptoms? UK Study Gives Encouraging Answer
September 02, 2021
From Benzinga
From Benzinga
Europe To Return Johnson & Johnson COVID-19 vaccines Shipped From South Africa: WSJ
September 02, 2021
Tickers
JNJ
From Benzinga
Regencell Bioscience Stock Jumps On Formation Of COVID-19 Treatment Focused Joint Venture
September 02, 2021
Tickers
RGC
From Benzinga
FDA Schedules Adcomm For Pfizer/BioNTech's COVID-19 Booster Shot
September 02, 2021
From Benzinga
Adamis Stock Jumps As Its Oral COVID-19 Drug Trial Starts Dosing
September 02, 2021
Tickers
ADMP
From Benzinga
Celsion's Vaccine Platform Shows Potential Against COVID-19 In Preclinical Studies
September 02, 2021
Tickers
CLSN
From Benzinga
Applied DNA Stock Jumps On New COVID-19 Testing Contract
September 02, 2021
Tickers
APDN
From Benzinga
Quidel To Bring OTC COVID-19 Antigen Test To CVS Pharmacy
September 02, 2021
From Benzinga
Pfizer Commences Dosing In Pivotal Oral COVID-19 Drug Trial
September 01, 2021
From Benzinga
CytoSorbents' Product Associated With High Survival In Critically Ill COVID-19 Patients
September 01, 2021
Tickers
CTSO
From Benzinga
Merck To Test Oral Antiviral Candidate For Post-Exposure Prophylaxis Of COVID-19 Infection
September 01, 2021
Tickers
MRK
From Benzinga
Moderna's COVID-19 Shot Elicits Higher Antibodies Than Pfizer/BioNTech Jab, Study Suggests
August 31, 2021
From Benzinga
Why Mesoblast Stock Is Plunging After Q4 Earnings Report?
August 31, 2021
Tickers
MESO
From Benzinga
From Benzinga
Can COVID-19 Antibody Treatment Help In High-Risk Cases? Mayo Clinic, nference Study Shows Potential
August 30, 2021
From Benzinga
NRx Pharma Stock Is Moving Higher On COVID-19 Candidate Data
August 30, 2021
Tickers
NRXP
From Benzinga
Oragenics's New Preclinical Data Supports Its Approach For COVID-19 Vaccine Development
August 30, 2021
Tickers
OGEN
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.